COLUMBIA LABORATORIES (CBRX) 0.95 $0.02 (2.15%) 09:30PM (15 mins delay)

CBRX

$0.95 $0.02 (2.15%)

You need to upgrade your Flash Player

Today

10y

Last:	$0.95	High:	-
Prev Close:	$0.93	Low:	-
Open:	-	Mkt Cap:	$61M
Change:	$0.02 ( 2.15% )	52Wk High:	$1.75
Vol:	0	52Wk Low:	$0.65
Avg Volume:	575,817	Shares:	65.63B
EPS:	-0.38	PE Ratio:	-

Start trading CBRX with real money!

Company Description

The Company is engaged in the research, development and commercialization of women's healthcare and endocrinology products, including treat infertility, endometriosis, dysmenorrhea and preterm birth.

	FreshlyBlended via Twitter	Oct 29 3:02 PM
	Columbia Laboratories Registered Direct Offering (NASDAQ $CBRX) http://bit.ly/3DYYyV Comment

	Leigh Jones via Twitter	Oct 23 10:28 AM
	$CBRX .9839 Scalp - no hold Comment

COLUMBIA LABORATORIES (CBRX) Stock News & Analysis

	Columbia Laboratories Comments on Stock Activity	11/13/2009
	"CRINONE(R) 8% (progesterone vaginal gel) As Effective as Hormone Injections During IVF" Is Medscape's "Top News" from The ASRM 65th Annual Meeting	11/09/2009
	Columbia Laboratories Reports Third Quarter 2009 Financial Results	11/05/2009
	Columbia Laboratories Closes Registered Direct Common Stock and Warrant Offering	10/28/2009
	Columbia Laboratories to Present at the Oppenheimer 20th Annual Healthcare Conference on November 3, 2009	10/27/2009
	Offerings Drive Shares Lower: CBRX, WRES, UQM	10/23/2009
	Columbia Laboratories Announces Registered Direct Common Stock Offering	10/23/2009
	Bleeding is Rare in IVF Patients Who Become Pregnant When Treated with a Combination of Vaginal Progesterone Gel and Estrogen	10/22/2009
	Columbia Laboratories to Discuss Third Quarter 2009 Financial Results on November 5, 2009 Conference Call	10/22/2009
	Capitol Acquisition and Two Harbors Name Independent Directors	10/21/2009
	CRINONE(R) 8% (Progesterone Gel) is Equally Effective and Significantly Better Tolerated Than Intramuscular Progesterone; Similar Pregnancy Rates and Outcomes Reported	10/21/2009
	Clinical Pregnancy Rates Comparable in Older Women Undergoing IVF-ET, Using Three Different Progesterone Preparations; Once Daily Vaginal Gel May Improve Compliance	10/20/2009
	Columbia Laboratories Enjoys Major Role at the 65th Annual Meeting of the American Society of Reproductive Medicine	10/19/2009
	Columbia Laboratories to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10, 2009	09/02/2009
	Columbia Laboratories Partners with RESOLVE: the National Infertility Association to Sponsor and Provide Web Content for Infertile Couples	08/11/2009